WO2001007625A3 - Ehrlichia canis genes and vaccines - Google Patents
Ehrlichia canis genes and vaccines Download PDFInfo
- Publication number
- WO2001007625A3 WO2001007625A3 PCT/US2000/019763 US0019763W WO0107625A3 WO 2001007625 A3 WO2001007625 A3 WO 2001007625A3 US 0019763 W US0019763 W US 0019763W WO 0107625 A3 WO0107625 A3 WO 0107625A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine
- vaccines
- ehrlichia canis
- proteins
- homolog
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000605312 Ehrlichia canis Species 0.000 title 1
- 229940051998 ehrlichia canis Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 abstract 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 abstract 1
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- -1 ORF Proteins 0.000 abstract 1
- 108090000233 Signal peptidase II Proteins 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 241000545125 Tetragoneuria canis Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001512891A JP2003505087A (en) | 1999-07-21 | 2000-07-20 | Genes and vaccines for Ehrlichiacanis |
MXPA02000748A MXPA02000748A (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines. |
CZ2002601A CZ2002601A3 (en) | 1999-07-21 | 2000-07-20 | Erlichia canis genes and vaccines |
EP00948815A EP1210438A2 (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
AU62257/00A AU772946B2 (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
BR0012556-3A BR0012556A (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
IL14773300A IL147733A0 (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
CA002375650A CA2375650A1 (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
HK03101577.6A HK1050708A1 (en) | 1999-07-21 | 2003-03-03 | Ehrlichia canis genes and vaccines |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35832299A | 1999-07-21 | 1999-07-21 | |
US09/358,322 | 1999-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001007625A2 WO2001007625A2 (en) | 2001-02-01 |
WO2001007625A3 true WO2001007625A3 (en) | 2001-10-11 |
Family
ID=23409210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/019763 WO2001007625A2 (en) | 1999-07-21 | 2000-07-20 | Ehrlichia canis genes and vaccines |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1210438A2 (en) |
JP (1) | JP2003505087A (en) |
CN (1) | CN1367832A (en) |
AU (1) | AU772946B2 (en) |
BR (1) | BR0012556A (en) |
CA (1) | CA2375650A1 (en) |
CZ (1) | CZ2002601A3 (en) |
HK (1) | HK1050708A1 (en) |
IL (1) | IL147733A0 (en) |
MX (1) | MXPA02000748A (en) |
WO (1) | WO2001007625A2 (en) |
ZA (1) | ZA200200035B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7335754B2 (en) | 1999-07-21 | 2008-02-26 | Cornell Research Foundation, Inc. | Ehrlichia canis genes and vaccines |
ATE461673T1 (en) | 2002-11-07 | 2010-04-15 | Abbott Lab | METHOD FOR APPLYING A MEDICATION TO A PROSTHESIS USING A LIQUID JET |
US20070248584A1 (en) * | 2003-06-10 | 2007-10-25 | The University Of Melbourne | Immunomodulating Compositions, Uses Therefore and Processes for Their Production |
US8828675B2 (en) * | 2009-11-20 | 2014-09-09 | Abaxis, Inc. | Peptides, devices, and methods for the detection of ehrlichia antibodies |
US9651546B2 (en) | 2012-10-11 | 2017-05-16 | Abaxis, Inc. | Peptides, devices, and methods for the detection of ehrlichia antibodies |
US9442112B2 (en) | 2014-04-04 | 2016-09-13 | Abaxis, Inc. | Compositions and methods for identifying Ehrlichia species |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016554A1 (en) * | 1996-10-17 | 1998-04-23 | University Of Florida | Nucleic acid vaccines against rickettsial diseases and methods of use |
WO1998042743A1 (en) * | 1997-03-24 | 1998-10-01 | Merial | Canine ehrlichiosis immunogenic and diagnostic compositions and methods |
WO1999013720A1 (en) * | 1997-09-19 | 1999-03-25 | The Ohio State Research Foundation | Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207169B1 (en) * | 1997-03-21 | 2001-03-27 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
-
2000
- 2000-07-20 CZ CZ2002601A patent/CZ2002601A3/en unknown
- 2000-07-20 JP JP2001512891A patent/JP2003505087A/en active Pending
- 2000-07-20 CA CA002375650A patent/CA2375650A1/en not_active Abandoned
- 2000-07-20 AU AU62257/00A patent/AU772946B2/en not_active Ceased
- 2000-07-20 MX MXPA02000748A patent/MXPA02000748A/en active IP Right Grant
- 2000-07-20 BR BR0012556-3A patent/BR0012556A/en not_active Application Discontinuation
- 2000-07-20 WO PCT/US2000/019763 patent/WO2001007625A2/en active IP Right Grant
- 2000-07-20 IL IL14773300A patent/IL147733A0/en not_active IP Right Cessation
- 2000-07-20 CN CN00810608A patent/CN1367832A/en active Pending
- 2000-07-20 EP EP00948815A patent/EP1210438A2/en not_active Withdrawn
-
2002
- 2002-01-02 ZA ZA200200035A patent/ZA200200035B/en unknown
-
2003
- 2003-03-03 HK HK03101577.6A patent/HK1050708A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016554A1 (en) * | 1996-10-17 | 1998-04-23 | University Of Florida | Nucleic acid vaccines against rickettsial diseases and methods of use |
WO1998042743A1 (en) * | 1997-03-24 | 1998-10-01 | Merial | Canine ehrlichiosis immunogenic and diagnostic compositions and methods |
WO1999013720A1 (en) * | 1997-09-19 | 1999-03-25 | The Ohio State Research Foundation | Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis |
Non-Patent Citations (10)
Title |
---|
ANDERSSON S G E ET AL., NATURE, vol. 396, 1998, pages 133 - 140 * |
DATABASE EMPRO1 EMBL Heidelberg, Germany; 1 May 1997 (1997-05-01), YAMANE K ET AL.: "The 25 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes", XP002163810 * |
DATABASE EMPRO1 EMBL Heidelberg, Germany; 21 November 1998 (1998-11-21), ANDERSSON S G E ET AL.: "The genome of sequence of Rickettsia prowazekii and the origin of mitochondria", XP002163811 * |
DATABASE EMPRO2 EMBL Heidelberg, Germany; 19 June 1997 (1997-06-19), FREIBERG C ET AL., XP002163809 * |
DATABASE EMPRO2 EMBL Heidelberg, Germany; 24 January 1996 (1996-01-24), SPRINGER A L ET AL., XP002163808 * |
DATABASE PIR2 EMBL, Heidelberg, Germany; 16 August 1996 (1996-08-16), XP002154411 * |
FREIBERG C ET AL: "MOLECULAR BASIS OF SYMBIOSIS BETWEEN RHIZOBIUM AND LEGUMES", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, vol. 387, no. 6631, 22 May 1997 (1997-05-22), pages 394 - 401, XP002047854, ISSN: 0028-0836 * |
SPRINGER AMY L ET AL: "Characterization and nucleotide sequence of pqqE and pqqF in Methylobacterium extorquens AM1.", JOURNAL OF BACTERIOLOGY, vol. 178, no. 7, 1996, pages 2154 - 2157, XP000990643, ISSN: 0021-9193 * |
WAGHELA S D ET AL.: "A cloned DNA probe identifies Cowdria ruminantium in Amblyomma variegatum ticks", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 29, no. 11, 1991, pages 2571 - 2577, XP000960522, ISSN: 0095-1137 * |
YAMANE K ET AL.: "Homologue of multidrug resistance protein B", MICROBIOLOGY, vol. 142, 1996, pages 3047 - 3056 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA02000748A (en) | 2003-07-14 |
IL147733A0 (en) | 2002-08-14 |
CA2375650A1 (en) | 2001-02-01 |
AU6225700A (en) | 2001-02-13 |
HK1050708A1 (en) | 2003-07-04 |
BR0012556A (en) | 2002-07-02 |
ZA200200035B (en) | 2003-10-02 |
EP1210438A2 (en) | 2002-06-05 |
CN1367832A (en) | 2002-09-04 |
JP2003505087A (en) | 2003-02-12 |
WO2001007625A2 (en) | 2001-02-01 |
AU772946B2 (en) | 2004-05-13 |
CZ2002601A3 (en) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010361A (en) | Genetic sequences of neisseria and use of these | |
WO2001031019A3 (en) | Neisserial antigenic peptides | |
KR101196178B1 (en) | Fusion protein of hiv regulatory/accessory proteins | |
SG152917A1 (en) | Neisseria meningitidis antigens | |
WO2001096377A3 (en) | Vaccine for congenital tremors in pigs | |
EP1559795A3 (en) | Neisseria genomic sequences and methods of their use | |
WO1999024578A3 (en) | Neisserial antigens | |
WO1997048370A3 (en) | Vaccines comprising synthetic genes | |
WO2002012525A3 (en) | Helper functions for recombinant vector production | |
EP1437400A3 (en) | Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus | |
WO2003089571A3 (en) | Ehrlichia canis genes and vaccines | |
WO2001007625A3 (en) | Ehrlichia canis genes and vaccines | |
DK0892054T3 (en) | Clostridium perfringens vaccine | |
WO2000052164A3 (en) | Potassium channel molecules and uses therefor | |
AU686000B2 (en) | Infectious peritonitis vaccine | |
NO20005482D0 (en) | Recombinant virus expressing foreign DNA encoding Felin CD80, Felin CTLA-4 or Felin CD86 and use thereof | |
WO2001032872A3 (en) | Twik potassium channel molecules and uses therefor | |
WO2006133795A3 (en) | A new human t-cell lymphotropic virus (htlv-3): nucleic acid and peptidic sequences thereof and method for detecting htlv-3 | |
WO1998046742A3 (en) | Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002/00035 Country of ref document: ZA Ref document number: 200200035 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 62257/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000948815 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2002/00062/DE Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2375650 Country of ref document: CA Ref document number: 2375650 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 147733 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008106088 Country of ref document: CN Ref document number: PA/a/2002/000748 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-601 Country of ref document: CZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2000948815 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-601 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 62257/00 Country of ref document: AU |